PMID- 10746544 OWN - NLM STAT- MEDLINE DCOM- 20000615 LR - 20191103 IS - 1524-9557 (Print) IS - 1524-9557 (Linking) VI - 23 IP - 2 DP - 2000 Mar-Apr TI - Antitumor activity of interleukin-18 on mouse glioma cells. PG - 184-9 AB - Interleukin-18 (IL-18) exhibits antitumor activity in various laboratory models. In the current study, brain tumors in naive mice regressed after an intratumoral injection of a single dose of recombinant IL-18 (rIL-18). Intraperitoneal rIL-18 substantially delayed the growth of subcutaneously inoculated gliomas but not gliomas located in the brain. Efficacy was reduced when studies were performed in mice depleted of natural killer cells. Although intracerebral administration of rIL-18 increased the serum interferon-gamma concentration, the antitumor effect of IL-18 was not mediated by interferon-gamma. These data suggest the therapeutic potential for control of tumor growth by intratumoral administration of rIL-18 in patients with glioma. FAU - Kikuchi, T AU - Kikuchi T AD - Department of Oncology, The Institute of DNA Medicine, Jikei University School of Medicine, Tokyo, Japan. FAU - Akasaki, Y AU - Akasaki Y FAU - Joki, T AU - Joki T FAU - Abe, T AU - Abe T FAU - Kurimoto, M AU - Kurimoto M FAU - Ohno, T AU - Ohno T LA - eng PT - Journal Article PL - United States TA - J Immunother JT - Journal of immunotherapy (Hagerstown, Md. : 1997) JID - 9706083 RN - 0 (Antineoplastic Agents) RN - 0 (Growth Inhibitors) RN - 0 (Interleukin-18) RN - 0 (Recombinant Proteins) SB - IM MH - Animals MH - Antineoplastic Agents/immunology/*therapeutic use MH - Cell Survival/immunology MH - Glioma/*immunology/*therapy MH - Growth Inhibitors/immunology/therapeutic use MH - Injections, Intralesional MH - Injections, Intraperitoneal MH - Injections, Subcutaneous MH - Interleukin-18/administration & dosage/immunology/*pharmacology/therapeutic use MH - Killer Cells, Natural/immunology/metabolism MH - Mice MH - Mice, Inbred A MH - Recombinant Proteins/immunology/*therapeutic use MH - Stereotaxic Techniques MH - Tumor Cells, Cultured EDAT- 2000/04/04 09:00 MHDA- 2000/06/17 09:00 CRDT- 2000/04/04 09:00 PHST- 2000/04/04 09:00 [pubmed] PHST- 2000/06/17 09:00 [medline] PHST- 2000/04/04 09:00 [entrez] AID - 10.1097/00002371-200003000-00002 [doi] PST - ppublish SO - J Immunother. 2000 Mar-Apr;23(2):184-9. doi: 10.1097/00002371-200003000-00002.